close
Share with your friends

M&A Report

M&A Report

The report provides an overview of the M&A activities in Switzerland.

The report provides an overview of the M&A activities in Switzerland.

The past year saw the merger and acquisition business cool down somewhat compared to the record-breaking year posted in 2018. The number of transactions with Swiss involvement dropped from 493 to 402; the transaction volume also declined to USD 127 billion (2018: USD 133 billion). This is one of the insights revealed by KPMG’s annual Clarity on M&A study.


Top 10 Swiss M&A transactions 2019

Announced date Target Stake in % Target country Bidder Bidder country Value (USDm)
February Alcon Inc. 100 Switzerland Novartis AG (Shareholders)
Switzerland 31,000
May Nestlé Skin Health SA 100 Switzerland EQT; Abu Dhabi Investment Authority
Sweden/UAE 10,200
November The Medicines Company 100 United States Novartis AG Switzerland 9,700
March WABCO 100 Switzerland / United States ZF Friedrichshafen AG
Germany 7,243
April Panalpina Welttransport Holding AG 100 Switzerland

DSV A/S

Denmark 4,742
December ReAssure Group Plc 100 United Kingdom Phoenix Group Holdings Limited United Kingdom

4,269

February Spark Therapeutics Inc. 100 United States
Roche Holding AG Switzerland 4,250
November StubHub, Inc. 100 United States
Viagogo AG Switzerland 4,050
December Nestlé United States, Inc. (US ice cream business)   United States
Froneri Limited United Kingdom 4,000
May Takeda Pharmaceutical Company Limited (Xiidra business)   United States
Novartis AG Switzerland 3,400
 

Number and value of deals per quarter